- £196.16bn
- £215.32bn
- $54.07bn
- 85
- 17
- 83
- 70
REG - AstraZeneca PLC - 1st Quarter Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 2
AnnouncementREG - AstraZeneca PLC - 1st Quarter Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 1
AnnouncementREG - AstraZeneca PLC - 1st Quarter Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 3
AnnouncementREG - Vanguard FTSE DevEUR - Net Asset Value(s) <Origin Href="QuoteRef">AZN.L</Origin> <Origin Href="QuoteRef">VEUR.L</Origin>
AnnouncementREG - AstraZeneca PLC - Collaboration with Celgene on PD-L1 in haematology <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ and Innate to collaborate in immuno-oncology <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Notice of Results <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Selumetinib granted Orphan Drug Designation by FDA <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Notice of AGM <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - COLLABORATION WITH DAIICHI SANKYO INC <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - POSITIVE PHASE III RESULTS FOR PT003 IN COPD <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - BRILINTA PEGASUS-TIMI 54 STUDY <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Filing of Form 20-F with SEC <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 7
AnnouncementREG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 6
AnnouncementREG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 5
AnnouncementREG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 4
Announcement